Ertapenem Administered Subcutaneously Versus Intravenously

NCT03218800 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

30

Enrollment

OTHER_GOV

Sponsor class

Stopped not enough participants due to COVID19 pandemia

Conditions

Urinary Tract Infections

Interventions

COMBINATION_PRODUCT: Ertapenem

Sponsor

Instituto Nacional de Cancer, Brazil